Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 20/2/2021
SIETES contiene 93212 citas

<< anterior 21 a 31 de 31 
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006;367:404-11. [Ref.ID 76131]
Türkdogan D, Onat F, Türe U, Pamir N. Phenytoin toxicity with mandibular tremor secondary to intravenous administration. Int J Clin Pharmacol Ther 2002;40:18-9. [Ref.ID 60141]
23. Cita con resumen
Tsunoda SM, Harris RZ, Christians U, Velez RL, Freeman RB, Benet LZ, Warshaw A. Red wine decreases cyclosporine bioavailability. Clin Pharmacol Ther 2001;70:462-7. [Ref.ID 60134]
Anónimo. Adverse drug reactions to lithium. Adv Drug React Bull 2001;206:787-90. [Ref.ID 55857]
25. Cita con resumen
Perucca E. Is there a role for therapeutic drug monitoring of new anticonvulsants?. Clin Pharmacokinet 2000;38:191-204. [Ref.ID 49672]
Anónimo. Generic drugs. Med Lett Drugs Ther 1999;41:47-8. [Ref.ID 45711]
27. Cita con resumen
Levy G. What are narrow therapeutic index drugs?. Clin Pharmacol Ther 1998;63:501-5. [Ref.ID 39161]
28. Cita con resumen
Birkett DJ. Pharmacodynamics - the concentration-effect relationship. Australian Prescriber 1995;18:102-4. [Ref.ID 25279]
Gleiter CH, Gundert-Remy U. Bioinequivalence and drug toxicity. How great is the problem and what can be done?. Drug Saf 1994;11:1-6. [Ref.ID 22153]
Brill-Edwards P, Ginsberg JS, Johnston M, Hirsh J. Establishing a therapeutic range for heparin therapy. Ann Intern Med 1993;119:104-9. [Ref.ID 19663]
31. Cita con resumen
Anónimo. Drug levels in epilepsy. Lancet 1975;2:264-7. [Ref.ID 833]
Seleccionar todas
<< anterior 21 a 31 de 31